nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Animal reservoirs for extended spectrum β-lactamase producers
|
Carattoli, A. |
|
2008 |
14 |
S1 |
p. 117-123 7 p. |
artikel |
2 |
Antibiotic policy and prescribing strategies for therapy of extended-spectrum β-lactamase-producing Enterobacteriaceae: the role of piperacillin–tazobactam
|
Peterson, L.R. |
|
2008 |
14 |
S1 |
p. 181-184 4 p. |
artikel |
3 |
Breakpoints for extended-spectrum β-lactamase-producing Enterobacteriacae: pharmacokinetic/pharmacodynamic considerations
|
MacGowan, A. |
|
2008 |
14 |
S1 |
p. 166-168 3 p. |
artikel |
4 |
Breakpoints for intravenously used cephalosporins in Enterobacteriaceae—EUCAST and CLSI breakpoints
|
Kahlmeter, G. |
|
2008 |
14 |
S1 |
p. 169-174 6 p. |
artikel |
5 |
Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community
|
Warren, R.E. |
|
2008 |
14 |
S1 |
p. 124-133 10 p. |
artikel |
6 |
Defining an extended-spectrum β-lactamase
|
Livermore, D.M. |
|
2008 |
14 |
S1 |
p. 3-10 8 p. |
artikel |
7 |
Evolution of extended-spectrum β-lactamases by mutation
|
Gniadkowski, M. |
|
2008 |
14 |
S1 |
p. 11-32 22 p. |
artikel |
8 |
Extended-spectrum β-lactamases and the permeability barrier
|
Martínez-Martínez, L. |
|
2008 |
14 |
S1 |
p. 82-89 8 p. |
artikel |
9 |
Extended-spectrum β-lactamases in ambulatory care: a clinical perspective
|
Rodríguez-Baño, J. |
|
2008 |
14 |
S1 |
p. 104-110 7 p. |
artikel |
10 |
Extended-spectrum β-lactamases in long-term-care facilities
|
Nicolas-Chanoine, Marie-Hélène |
|
2008 |
14 |
S1 |
p. 111-116 6 p. |
artikel |
11 |
Extended-spectrum β-lactamases in North America, 1987–2006
|
Bush, K. |
|
2008 |
14 |
S1 |
p. 134-143 10 p. |
artikel |
12 |
Extended-spectrum β-lactamases: structure and kinetic mechanism
|
Page, M.G.P. |
|
2008 |
14 |
S1 |
p. 63-74 12 p. |
artikel |
13 |
Genetic support of extended-spectrum β-lactamases
|
Poirel, L. |
|
2008 |
14 |
S1 |
p. 75-81 7 p. |
artikel |
14 |
IRT and CMT β-lactamases and inhibitor resistance
|
Cantón, R. |
|
2008 |
14 |
S1 |
p. 53-62 10 p. |
artikel |
15 |
β-Lactams without a suicide inhibitor
|
Giamarellou, H. |
|
2008 |
14 |
S1 |
p. 194-197 4 p. |
artikel |
16 |
Living with ESBLs
|
Cornaglia, G. |
|
2008 |
14 |
S1 |
p. 1-2 2 p. |
artikel |
17 |
Minor extended-spectrum β-lactamases
|
Naas, T. |
|
2008 |
14 |
S1 |
p. 42-52 11 p. |
artikel |
18 |
Orthodox and unorthodox clavulanate combinations against extended-spectrum β-lactamase producers
|
Livermore, D.M. |
|
2008 |
14 |
S1 |
p. 189-193 5 p. |
artikel |
19 |
Other antimicrobials of interest in the era of extended-spectrum β-lactamases: fosfomycin, nitrofurantoin and tigecycline
|
Garau, J. |
|
2008 |
14 |
S1 |
p. 198-202 5 p. |
artikel |
20 |
Parenteral carbapenems
|
Shah, P.M. |
|
2008 |
14 |
S1 |
p. 175-180 6 p. |
artikel |
21 |
Phenotypic detection of extended-spectrum β-lactamase production in Enterobacteriaceae: review and bench guide
|
Drieux, L. |
|
2008 |
14 |
S1 |
p. 90-103 14 p. |
artikel |
22 |
Prevalence and clonality of extended-spectrum β-lactamases in Asia
|
Hawkey, P.M. |
|
2008 |
14 |
S1 |
p. 159-165 7 p. |
artikel |
23 |
Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe
|
Cantón, R. |
|
2008 |
14 |
S1 |
p. 144-153 10 p. |
artikel |
24 |
Prevalence of extended-spectrum β-lactamases in South America
|
Villegas, M.V. |
|
2008 |
14 |
S1 |
p. 154-158 5 p. |
artikel |
25 |
Sulbactam-containing β-lactamase inhibitor combinations
|
Akova, M. |
|
2008 |
14 |
S1 |
p. 185-188 4 p. |
artikel |
26 |
The spread of CTX-M-type extended-spectrum β-lactamases
|
Rossolini, G.M. |
|
2008 |
14 |
S1 |
p. 33-41 9 p. |
artikel |